Introduction: Chronic lower extremity arterial disease is increasingly common, particularly among elderly patients with multiple comorbidities. Drug-eluting stents have emerged as an effective endovascular option, offering improved patency and reduced restenosis. This study is to evaluate the initial outcomes of drug-eluting stent placement for chronic lower extremity arterial disease at Thong Nhat Hospital. Patients and Methods: A retrospective case-series study was conducted on 35 patients with chronic lower extremity arterial disease who underwent endovascular drug-eluting stent placement between 1/2022 and 12/2024. Outcome measures included changes in Rutherford classification, ankle–brachial index (ABI), wound healing rate, vascular patency, and mortality. Clinical and imaging follow-up assessments were performed at 6, 12, and 24 months after the intervention. Results: Significant improvement in clinical symptoms and ABI values was observed at follow-up (p < 0.001). Wound healing rates were 84.6% at 6 months and 100% at 24 months. Primary patency at 24 months was 88.6%. Conclusions: Drug-eluting stent placement demonstrates favorable mid-term efficacy in improving limb perfusion and wound healing with an acceptable safety profile in patients with chronic lower extremity arterial disease.
No takes yet. Share an insight, caveat, or question.
Nguyễn et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: